Q-omics provides the consensus-scored RNU6-311P profile across patient tissues and cancer cell-line models. RNU6-311P expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, RNU6-311P RNA expression shows 6,030 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where RNU6-311P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-311P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-311P survival associations across molecular data types. RNU6-311P RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-311P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	10	STAD (36)	view →

This table ranks reproducible RNU6-311P RNA expression–survival associations across cancer types. High RNU6-311P expression shows unfavorable associations in COAD, THCA, GBM, THYM and SARC, but favorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify STAD as the clearest survival context for RNU6-311P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	1.000	0.166	.001	36	view →
COAD	DFS	Tertile	III,IV	0.167	0.667	.029	18	view →
THCA	OS	Tertile	III,IV	0.171	0.788	.001	18	view →
GBM	DFS	Tertile	All	0.122	0.263	.013	18	view →
THYM	DFS	Tertile	All	0.107	0.884	.001	18	view →
SARC	OS	Tertile	All	0.524	0.832	.030	15	view →

Pink = unfavorable, green = favorable. all 10 lineages →

RNU6-311P-STAD (OS)

Kaplan–Meier survival curve for RNU6-311P RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-311P in patient tissues and cancer cell lines. In patient samples, RNU6-311P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,030	STAD (5623)	view →
RNA	4,573	HNSC (1606)	view →